VHL tumor suppressor regulates Cl-/HCO3- exchange and Na+/H+ exchange activities in renal carcinoma cells

Physiological Genomics

Volumn 2001, Issue 5, 2001, Pages 119-128

  Karumanchi, S Ananth ^a   Jiang, Lianwei ^a   Knebelmann, Bertrand ^a   Stuart Tilley, Alan K ^a   Alper, Seth L ^a,b   Sukhatme, Vikas P ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

AE2; Intracellular pH; NHE3; Renal cell carcinoma; Von Hippel Lindau disease

Indexed keywords

TRIXIS;

AE2 ANION EXCHANGER; AMMONIUM CHLORIDE; ANION TRANSPORT PROTEIN; ANTIPORTER; BICARBONATE CHLORIDE ANTIPORTER; CARBONATE DEHYDRATASE; GROWTH FACTOR ACTIVATABLE NA H EXCHANGER NHE 1; GROWTH FACTOR-ACTIVATABLE NA-H EXCHANGER NHE-1; HYPERTONIC SOLUTION; LIGASE; MEMBRANE PROTEIN; PROTEIN; RNA; SODIUM PROTON EXCHANGE PROTEIN; SODIUM PROTON EXCHANGE PROTEIN 3; SODIUM-HYDROGEN EXCHANGER 3; TUMOR SUPPRESSOR PROTEIN; UBIQUITIN PROTEIN LIGASE; VHL PROTEIN, HUMAN; VON HIPPEL LINDAU PROTEIN;

ARTICLE; BIOSYNTHESIS; CELL CULTURE; COMPARATIVE STUDY; DOWN REGULATION; GENE DELETION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; HUMAN; KIDNEY CARCINOMA; METABOLISM; PH; PHYSIOLOGY; TUMOR SUPPRESSOR GENE; UPREGULATION;

AMMONIUM CHLORIDE; ANION TRANSPORT PROTEINS; ANTIPORTERS; CARBONIC ANHYDRASES; CARCINOMA, RENAL CELL; CHLORIDE-BICARBONATE ANTIPORTERS; DOWN-REGULATION; GENE DELETION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, TUMOR SUPPRESSOR; HUMANS; HYDROGEN-ION CONCENTRATION; HYPERTONIC SOLUTIONS; LIGASES; MEMBRANE PROTEINS; PROTEINS; RNA, NEOPLASM; SODIUM-HYDROGEN ANTIPORTER; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEINS; UBIQUITIN-PROTEIN LIGASES; UP-REGULATION; VON HIPPEL-LINDAU TUMOR SUPPRESSOR PROTEIN;

EID: 0035795336     PISSN: 15312267     EISSN: None     Source Type: Journal    
DOI: 10.1152/physiolgenomics.2001.5.3.119     Document Type: Article

References (64)

1. +-ATPaSe rather than with basolateral anion exchanger AE2. J Clin Invest 93: 1430-1438, 1994.
2. Alper SL, Stuart-Tilley AK, Biemesderfer D, Shmukler BE, and Brown D. Immunolocalization of AE2 anion exchanger in rat kidney. Am J Physiol Renal Physiol 273: F601-F614, 1997.
3. Alper SL, Stuart-Tilley AK, Yannoukakos D, and Brown D. AE3 anion exchanger immunolocalization in rodent kidney: evidence for apical and basolateral isoforms (Abstract). J Am Soc Nephrol 6: 1428, 1995.
4. Ananth S, Knebelmann B, Gruning W, Dhanabal M, Walz G, Stillman IE, and Sukhatme VP. Transforming growth factor β1 is a target for the von Hippel-Lindau tumor suppressor and a critical growth factor for clear cell renal carcinoma. Cancer Res 59: 2210-2216, 1999.
5. Ananth S, Knebelmann B, Lee SW, and Sukhatme VP. Identification of 4 novel targets for the VHl tumor suppressor (Abstract). J Am Soc Nephrol 10: 2170, 1999.
6. Aso T, Lane WS, Conaway JW, and Conaway RC. Elongin (SIII): a multisubunit regulator of elongation by RNA polymerase II. Science 269: 1439-1443, 1995.
7. + antiport to osmotic stress. Am J Physiol Cell Physiol 269: C998-C1007, 1995.
8. + exchanger isoform of renal brush border. Am J Physiol Renal Fluid Electrolyte Physiol 265: F736-F742, 1993.
9. Biemesderfer D, Rutherford PA, Nagy T, Pizzonia JH, Abu-Alfa AK, and Aronson PS. Monoclonal antibodies for high-resolution localization of NHE3 in adult and neonatal rat kidney. Am J Physiol Renal Physiol 273: F289-F299, 1997.
10. Brosius, FC, Nguyen K, Stuart-Tilley AK, Haller C, Briggs JP, and Alper SL. Regional and segmental localization of AE2 anion exchanger mRNA and protein in rat kidney. Am J Physiol Renal Fluid Electrolyte Physiol 269: F461-F468, 1995.
11. Brown D, Lydon J, McLaughlin M, Stuart-Tilley A, Tyszkowski R, and Alper S. Antigen retrieval in cryostat tissue sections and cultured cells by treatment with sodium dodecyl sulfate (SDS). Histochem Cell Biol 105: 261-267, 1996.
12. + exchanger in rat renal cortical tubules. Am J Physiol Cell Physiol 273: C1064-C1074, 1997.
13. + exchanger isoform NHE2 in rat kidney. Am J Physiol Renal Physiol 275: F379-F386, 1998.
14. Choukroun GJ, Marshansky V, Gustafson CE, McKee M, Hajjar RJ, Rosenzweig A, Brown D, and Bonventre JV. Cytosolic phospholipase A2 regulates Golgi structure and modulates intracellular trafficking of membrane proteins. J Clin Invest 106: 983-993, 2000.
15. + antiporter isoforms using amiloride analogs and a new inhibitor exhibiting anti-ischemic properties. Mol Pharmacol 44: 1041-1045, 1993.
16. Duan DR, Pause A, Burgess WH, Aso T, Chen DY, Garrett KP, Conaway RC, Conaway JW, Linehan WM, and Klausner RD. Inhibition of transcription elongation by the VHL tumor suppressor protein. Science 269: 1402-1406, 1995.
17. - exchanger isoforms in proximal and distal human airways. Am J Physiol Lung Cell Mol Physiol 276: L971-L978, 1999.
18. Flier JS, Mueckler MM, Usher P, and Lodish HF. Elevated levels of glucose transport and transporter messenger RNA are induced by ras or src oncogenes. Science 235: 1492-1495, 1987.
19. Gillen CM and Forbush B III. Functional interaction of the K-Cl cotransporter (KCC1) with the Na-K-Cl cotransporter in HEK-293 cells. Am J Physiol Cell Physiol 276: C328-C336, 1999.
20. Gnarra JR, Tory K, Weng Y, Schmidt L, Wei MH, Li H, Latif F, Liu S, Chen F, Duh FM, Lubensky I, Duan DR, Florence C, Pozzatti R, Walther MM, Bander NH, Grossman HB, Branch H, Pomer S, Brooks JD, Isaacs WB, Lerman MI, Zbar B, and Lineham WM. Mutations of the VHL tumour suppressor gene in renal carcinoma. Nat Genet 7: 85-90, 1994.
21. Gnarra JR, Ward JM, Porter FD, Wagner JR, Devor DE, Grinberg A, Emmert-Buck MR, Westphal H, Klausner RD, and Linehan WM. Defective placental vasculogenesis causes embryonic lethality in VHL-deficient mice. Proc Natl Acad Sci USA 94: 9102-9107, 1997.
22. Gnarra JR, Zhou S, Merrill MJ, Wagner JR, Krumm A, Papavassiliou E, Oldfield EH, Klausner RD, and Linehan WM. Post-transcriptional regulation of vascular endothelial growth factor mRNA by the product of the VHL tumor suppressor gene. Proc Natl Acad Sci USA 93: 10589-10594, 1996.
23. Gorospe M, Egan JM, Zbar B, Lerman M, Geil L, Kuzmin I, and Holbrook NJ. Protective function of von Hippel-Lindau protein against impaired protein processing in renal carcinoma cells. Mol Cell Biol 19: 1289-1300, 1999.
24. Humphreys BD, Jiang L, Chernova MN, and Alper SL. Functional characterization and regulation by pH of murine AE2 anion exchanger expressed in Xenopus oocytes. Am J Physiol Cell Physiol 267: C1295-C1307, 1994.
25. Humphreys BD, Jiang L, Chernova MN, and Alper SL. Hypertonic activation of AE2 anion exchanger in Xenopus oocytes via NHE-mediated intracellular alkalinization. Am J Physiol Cell Physiol 268: C201-C209, 1995.
26. Hiopoulos O, Kibel A, Gray S, and Kaelin WG Jr. Tumour suppression by the human von Hippel-Lindau gene product. Nat Med 1: 822-826, 1995.
27. Hiopoulos O, Levy AP, Jiang C, Kaelin WG Jr, and Goldberg MA. Negative regulation of hypoxia-inducible genes by the von Hippel-Lindau protein. Proc Natl Acad Sci USA 93: 10595-10599, 1996.
28. + receptor. Proc Natl Acad SCI USA 96: 9949-9953, 1999.
29. 3 exchange in basolateral Cl transport of rabbit proximal tubules. Am J Physiol Renal Fluid Electrolyte Physiol 264: F251-F258, 1993.
30. Ivanov SV, Kuzmin I, Wei MH, Pack S, Geil L, Johnson BE, Stanbridge EJ, and Lerman MI. Downregulation of transmembrane carbonic anhydrases in renal cell carcinoma cell lines by wild-type von Hippel-Lindau transgenes. Proc Natl Acad Sci USA 95: 12596-12601, 1998.
31. Iwai K, Yamanaka K, Kamura T, Minato N, Conaway RC, Conaway JW, Klausner RD, and Pause A. Identification of the von Hippel-Lindau tumor-suppressor protein as part of an active E3 ubiquitin ligase complex. Proc Natl Acad Sci USA 96: 12436-12441, 1999.
32. - exchange in CHOP cells of defined transient transfection status. Am J Physiol Cell Physiol 267: C845-C856, 1994.
33. Kaelin WG Jr and Maher ER. The VHL tumour-suppressor gene paradigm. Trends Genet 14: 423-426, 1998.
34. Kamura T, Conrad MN, Yan Q, Conaway RC, and Conaway JW. The Rbx1 subunit of SCF and VHL E3 ubiquitin ligase activates Rub1 modification of cullins Cdc53 and Cul2. Genes Dev 13: 2928-2933, 1999.
35. - exchangers in migrating renal epithelial cells. J Gen Physiol 115: 599-608, 2000.
36. Knebelmann B, Ananth S, Cohen HT, and Sukhatme VP. Transforming growth factor alpha is a target for the von Hippel-Lindau tumor suppressor. Cancer Res 58: 226-231, 1998.
37. -/base exchange in the rabbit S3 proximal tubule. J Clin Invest 83: 616-622, 1989.
38. + antiport in cancer. Cancer Biochem Biophys 9: 1-14, 1986.
39. Lee BS, Gunn RB, and Kopito RR. Functional differences among nonerythroid anion exchangers expressed in a transfected human cell line. J Biol Chem 266: 11448-11454, 1991.
40. Liao SY, Aurelio ON, Jan K, Zavada J, and Stanbridge EJ. Identification of the MN/CA9 protein as a reliable diagnostic biomarker of clear cell carcinoma of the kidney. Cancer Res 57: 2827-2831, 1997.
41. Linehan WM, Lerman MI, and Zbar B. Identification of the von Hippel-Lindau (VHL) gene. Its role in renal cancer. JAMA 273: 564-570, 1995.
42. Lisztwan J, Imbert G, Wirbelauer C, Gstaiger M, and Krek W. The von Hippel-Lindau tumor suppressor protein is a component of an E3 ubiquitin-protein ligase activity. Genes Dev 13: 1822-1833, 1999.
43. Lonergan KM, Iliopoulos O, Ohh M, Kamura T, Conaway RC, Conaway JW, and Kaelin WG Jr. Regulation of hypoxia-inducible mRNAs by the von Hippel-Lindau tumor suppressor protein requires binding to complexes containing elongins B/C and Cul2. Mol Cell Biol 18: 732-741, 1998.
44. Lubensky IA, Gnarra JR, Bertheau P, Walther MM, Linehan WM, and Zhuang Z. Allelic deletions of the VHL gene detected in multiple microscopic clear cell renal lesions in von Hippel-Lindau disease patients. Am J Pathol 149: 2089-2094, 1996.
45. Maxwell PH, Wiesener MS, Chang GW, Clifford SC, Vaux EC, Cockman ME, Wykoff CC, Pugh CW, Maher ER, and Ratcliffe PJ. The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature 399: 271-275, 1999.
46. Mukhopadhyay D, Knebelmann B, Cohen HT, Ananth S, and Sukhatme VP. The von Hippel-Lindau tumor suppressor gene product interacts with Sp1 to repress vascular endothelial growth factor promoter activity. Mol Cell Biol 17: 5629-5639, 1997.
47. Ohh M, Yauch RL, Lonergan KM, Whaley JM, Stemmer-Rachamimov AO, Louis DN, Gavin BJ, Kley N, Kaelin WG Jr, and Iliopoulos O. The von Hippel-Lindau tumor suppressor protein is required for proper assembly of an extracellular fibronectin matrix. Mol Cell 1: 959-968, 1998.
48. Parkkila S, Parkkila AK, Saarnio J, Kivela J, Karttunen TJ, Kaunisto K, Waheed A, Sly WS, Tureci O, Virtanen I, and Rajaniemi H. Expression of the membrane-associated carbonic anhydrase isozyme XII in the human kidney and renal tumors. J Histochem Cytochem 48: 1601-1608, 2000.
49. Parkkila S, Rajaniemi H, Parkkila AK, Kivela J, Waheed A, Pastorekova S, Pastorek J, and Sly WS. Carbonic anhydrase inhibitor suppresses invasion of renal cancer cells in vitro. Proc Natl Acad Sci USA 97: 2220-2224, 2000.
50. Pause A, Aso T, Linehan WM, Conaway JW, Conaway RC, and Klausner RD. Interaction of von Hippel-Lindau tumor suppressor gene product with elongin. Methods Enzymol 274: 436-441, 1996.
51. Pause A, Lee S, Worrell RA, Chen DY, Burgess WH, Linehan WM, and Klausner RD. The von Hippel-Lindau tumor-suppressor gene product forms a stable complex with human CUL-2, a member of the Cdc53 family of proteins. Proc Natl Acad Sci USA 94: 2156-2161, 1997.
52. Scott DA and Karniski LP. Human pendrin expressed in Xenopus laevis oocytes mediates chloride/formate exchange. Am J Physiol Cell Physlol 278: C207-C211, 2000.
53. -/base exchanger isoform in the rat proximal tubule (Abstract). J Am Soc Nephrol 5: 263A, 1994.
54. Stebbins CE, Kaelin WG Jr, and Pavletich NP. Structure of the VHL-ElonginC-ElonginB complex: implications for VHL tumor suppressor function. Science 284: 455-461, 1999.
55. 36Cl-efflux in AE2 expressing Xenopus laevis oocytes. J Physiol (Lond) 527: 34P, 2000.
56. Stewart AK, Chernova MN, and Alper SL. Critical residues in the regulatory "pH modifier site" in the N-terminal cytoplasmic domain of the AE2 anion exchanger expressed in Xenopus oocytes (Abstract). J Am Soc Nephrol 11: 10, 2000.
57. Stuart-Tilley A, Sardet C, Pouyssegur J, Schwartz MA, Brown D, and Alper SL. Immunolocalization of anion exchanger AE2 and cation exchanger NHE-1 in distinct adjacent cells of gastric mucosa. Am J Physiol Cell Physiol 266: C559-C568, 1994.
58. Tominaga T and Barber DL. Na-H exchange acts downstream of RhoA to regulate integrin-induced cell adhesion and spreading. Mol Biol Cell 9: 2287-2303, 1998.
59. Tominaga T, Ishizaki T, Narumiya S, and Barber DL. p160ROCK mediates RhoA activation of Na-H exchange. EMBO J 17: 4712-4722, 1998.
60. Tureci O, Sahin U, Vollmar E, Siemer S, Gottert E, Seitz G, Parkkila AK, Shah GN, Grubb JH, Pfreundschuh M, and Sly WS. Human carbonic anhydrase XII: cDNA cloning, expression, and chromosomal localization of a carbonic anhydrase gene that is overexpressed in some renal cell cancers. Proc Natl Acad Sci USA 95: 7608-7613, 1998.
61. Tyers M and Rottapel R. VHL: a very hip ligase. Proc Natl Acad Sci USA 96: 12230-12232, 1999.
62. Wahl ML, Pooler PM, Briand P, Leeper DB, and Owen CS. Intracellular pH regulation in a nonmalignant and a derived malignant human breast cell line. J Cell Physlol 183: 373-380, 2000.
63. Yannoukakos D, Stuart-Tilley A, Fernandez HA, Fey P, Duyk G, and Alper SL. Molecular cloning, expression, and chromosomal localization of two isoforms of the AE3 anion exchanger from human heart. Circ Res 75: 603-614, 1994.
64. Zhang Y, Chernova MN, Stuart-Tilley AK, Jiang L, and Alper SL. The cytoplasmic and transmembrane domains of AE2 both contribute to regulation of anion exchange by pH. J Biol Chem 271: 5741-5749, 1996.